Loading…
Chromosomal microarray in fetuses with increased nuchal translucency
ABSTRACT Objective To assess the clinical value of using high‐resolution chromosomal microarray (CMA) for the examination of genomic imbalances in prenatal uncultured chorionic villus samples from fetuses with increased nuchal translucency (NT) and a normal quantitative fluorescent polymerase chain...
Saved in:
Published in: | Ultrasound in obstetrics & gynecology 2015-01, Vol.45 (1), p.95-100 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4216-c75a05020635a988e347daa59096989ec307651f1d8555865189549780a9c7ee3 |
---|---|
cites | cdi_FETCH-LOGICAL-c4216-c75a05020635a988e347daa59096989ec307651f1d8555865189549780a9c7ee3 |
container_end_page | 100 |
container_issue | 1 |
container_start_page | 95 |
container_title | Ultrasound in obstetrics & gynecology |
container_volume | 45 |
creator | Lund, I. C. B. Christensen, R. Petersen, O. B. Vogel, I. Vestergaard, E. M. |
description | ABSTRACT
Objective
To assess the clinical value of using high‐resolution chromosomal microarray (CMA) for the examination of genomic imbalances in prenatal uncultured chorionic villus samples from fetuses with increased nuchal translucency (NT) and a normal quantitative fluorescent polymerase chain reaction (QF‐PCR) result, in a clinical setting in which more than 95% of pregnant women receive first‐trimester combined screening.
Methods
From January 2013 to July 2014, we included 132 chorionic villus samples from consecutive ongoing pregnancies, with fetal NT ≥ 3.5 mm at 11–13 weeks' gestation, from obstetric units (publicly funded healthcare) in Central and North Denmark Regions. DNA was extracted directly from the samples and examined with QF‐PCR (n = 132) and 180 kb oligonucleotide array‐based comparative genomic hybridization (n = 94).
Results
In 38 cases, aneuploidies for chromosomes 18, 21 or X, or triploidy, were detected by QF‐PCR. Among the 94 cases with a normal QF‐PCR result, we detected pathogenic copy number variants (CNVs) by CMA in 12 fetuses (12.8% (95% CI, 7.5–21.0%)). In an additional three (3.2%) cases, CNVs with uncertain clinical significance were detected.
Conclusion
CMA is a valuable diagnostic technique in pregnancies with isolated fetal NT ≥ 3.5 mm. Copyright © 2014 ISUOG. Published by John Wiley & Sons Ltd. |
doi_str_mv | 10.1002/uog.14726 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1647016180</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1647016180</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4216-c75a05020635a988e347daa59096989ec307651f1d8555865189549780a9c7ee3</originalsourceid><addsrcrecordid>eNqN0U9LwzAYBvAgipvTg19ACl700O1N0yTNUeZfGOziziGmqetom5m0jH57Mzs9CIKnvIEfD8n7IHSJYYoBklln36c45Qk7QmOcMhEDB3qMxiAYxJyJZITOvN8AAEsJO0WjhBJBEgxjdD9fO1tbb2tVRXWpnVXOqT4qm6gwbeeNj3Zluw537YzyJo-aTq-DbZ1qfNVp0-j-HJ0UqvLm4nBO0Orx4XX-HC-WTy_zu0Ws0wSzWHOqgEICjFAlssyQlOdKURHeKTJhNAHOKC5wnlFKszBmgqaCZ6CE5saQCboZcrfOfnTGt7IuvTZVpRpjOy8xSzlghjP4D00Yxpjv6fUvurGda8JH9goTIcKOg7odVFiR984UcuvKWrleYpD7FmRoQX61EOzVIbF7q03-I7_XHsBsALuyMv3fSXK1fBoiPwEqhY4-</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1641399002</pqid></control><display><type>article</type><title>Chromosomal microarray in fetuses with increased nuchal translucency</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Lund, I. C. B. ; Christensen, R. ; Petersen, O. B. ; Vogel, I. ; Vestergaard, E. M.</creator><creatorcontrib>Lund, I. C. B. ; Christensen, R. ; Petersen, O. B. ; Vogel, I. ; Vestergaard, E. M.</creatorcontrib><description>ABSTRACT
Objective
To assess the clinical value of using high‐resolution chromosomal microarray (CMA) for the examination of genomic imbalances in prenatal uncultured chorionic villus samples from fetuses with increased nuchal translucency (NT) and a normal quantitative fluorescent polymerase chain reaction (QF‐PCR) result, in a clinical setting in which more than 95% of pregnant women receive first‐trimester combined screening.
Methods
From January 2013 to July 2014, we included 132 chorionic villus samples from consecutive ongoing pregnancies, with fetal NT ≥ 3.5 mm at 11–13 weeks' gestation, from obstetric units (publicly funded healthcare) in Central and North Denmark Regions. DNA was extracted directly from the samples and examined with QF‐PCR (n = 132) and 180 kb oligonucleotide array‐based comparative genomic hybridization (n = 94).
Results
In 38 cases, aneuploidies for chromosomes 18, 21 or X, or triploidy, were detected by QF‐PCR. Among the 94 cases with a normal QF‐PCR result, we detected pathogenic copy number variants (CNVs) by CMA in 12 fetuses (12.8% (95% CI, 7.5–21.0%)). In an additional three (3.2%) cases, CNVs with uncertain clinical significance were detected.
Conclusion
CMA is a valuable diagnostic technique in pregnancies with isolated fetal NT ≥ 3.5 mm. Copyright © 2014 ISUOG. Published by John Wiley & Sons Ltd.</description><identifier>ISSN: 0960-7692</identifier><identifier>EISSN: 1469-0705</identifier><identifier>DOI: 10.1002/uog.14726</identifier><identifier>PMID: 25393210</identifier><identifier>CODEN: UOGYFJ</identifier><language>eng</language><publisher>Chichester, UK: John Wiley & Sons, Ltd</publisher><subject>array comparative genomic hybridization ; chromosomal microarray ; Chromosomes ; Down syndrome ; Down Syndrome - diagnosis ; Down Syndrome - embryology ; Down Syndrome - genetics ; Female ; Fetuses ; genomic imbalance ; Humans ; nuchal translucency ; Nuchal Translucency Measurement - methods ; Polymerase Chain Reaction ; Pregnancy ; Pregnancy Trimester, First ; Pregnancy, High-Risk ; prenatal diagnosis ; Prenatal Diagnosis - methods ; Prospective Studies ; Reproducibility of Results</subject><ispartof>Ultrasound in obstetrics & gynecology, 2015-01, Vol.45 (1), p.95-100</ispartof><rights>Copyright © 2014 ISUOG. Published by John Wiley & Sons Ltd</rights><rights>Copyright © 2014 ISUOG. Published by John Wiley & Sons Ltd.</rights><rights>Copyright © 2015 ISUOG. Published by John Wiley & Sons Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4216-c75a05020635a988e347daa59096989ec307651f1d8555865189549780a9c7ee3</citedby><cites>FETCH-LOGICAL-c4216-c75a05020635a988e347daa59096989ec307651f1d8555865189549780a9c7ee3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25393210$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lund, I. C. B.</creatorcontrib><creatorcontrib>Christensen, R.</creatorcontrib><creatorcontrib>Petersen, O. B.</creatorcontrib><creatorcontrib>Vogel, I.</creatorcontrib><creatorcontrib>Vestergaard, E. M.</creatorcontrib><title>Chromosomal microarray in fetuses with increased nuchal translucency</title><title>Ultrasound in obstetrics & gynecology</title><addtitle>Ultrasound Obstet Gynecol</addtitle><description>ABSTRACT
Objective
To assess the clinical value of using high‐resolution chromosomal microarray (CMA) for the examination of genomic imbalances in prenatal uncultured chorionic villus samples from fetuses with increased nuchal translucency (NT) and a normal quantitative fluorescent polymerase chain reaction (QF‐PCR) result, in a clinical setting in which more than 95% of pregnant women receive first‐trimester combined screening.
Methods
From January 2013 to July 2014, we included 132 chorionic villus samples from consecutive ongoing pregnancies, with fetal NT ≥ 3.5 mm at 11–13 weeks' gestation, from obstetric units (publicly funded healthcare) in Central and North Denmark Regions. DNA was extracted directly from the samples and examined with QF‐PCR (n = 132) and 180 kb oligonucleotide array‐based comparative genomic hybridization (n = 94).
Results
In 38 cases, aneuploidies for chromosomes 18, 21 or X, or triploidy, were detected by QF‐PCR. Among the 94 cases with a normal QF‐PCR result, we detected pathogenic copy number variants (CNVs) by CMA in 12 fetuses (12.8% (95% CI, 7.5–21.0%)). In an additional three (3.2%) cases, CNVs with uncertain clinical significance were detected.
Conclusion
CMA is a valuable diagnostic technique in pregnancies with isolated fetal NT ≥ 3.5 mm. Copyright © 2014 ISUOG. Published by John Wiley & Sons Ltd.</description><subject>array comparative genomic hybridization</subject><subject>chromosomal microarray</subject><subject>Chromosomes</subject><subject>Down syndrome</subject><subject>Down Syndrome - diagnosis</subject><subject>Down Syndrome - embryology</subject><subject>Down Syndrome - genetics</subject><subject>Female</subject><subject>Fetuses</subject><subject>genomic imbalance</subject><subject>Humans</subject><subject>nuchal translucency</subject><subject>Nuchal Translucency Measurement - methods</subject><subject>Polymerase Chain Reaction</subject><subject>Pregnancy</subject><subject>Pregnancy Trimester, First</subject><subject>Pregnancy, High-Risk</subject><subject>prenatal diagnosis</subject><subject>Prenatal Diagnosis - methods</subject><subject>Prospective Studies</subject><subject>Reproducibility of Results</subject><issn>0960-7692</issn><issn>1469-0705</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqN0U9LwzAYBvAgipvTg19ACl700O1N0yTNUeZfGOziziGmqetom5m0jH57Mzs9CIKnvIEfD8n7IHSJYYoBklln36c45Qk7QmOcMhEDB3qMxiAYxJyJZITOvN8AAEsJO0WjhBJBEgxjdD9fO1tbb2tVRXWpnVXOqT4qm6gwbeeNj3Zluw537YzyJo-aTq-DbZ1qfNVp0-j-HJ0UqvLm4nBO0Orx4XX-HC-WTy_zu0Ws0wSzWHOqgEICjFAlssyQlOdKURHeKTJhNAHOKC5wnlFKszBmgqaCZ6CE5saQCboZcrfOfnTGt7IuvTZVpRpjOy8xSzlghjP4D00Yxpjv6fUvurGda8JH9goTIcKOg7odVFiR984UcuvKWrleYpD7FmRoQX61EOzVIbF7q03-I7_XHsBsALuyMv3fSXK1fBoiPwEqhY4-</recordid><startdate>201501</startdate><enddate>201501</enddate><creator>Lund, I. C. B.</creator><creator>Christensen, R.</creator><creator>Petersen, O. B.</creator><creator>Vogel, I.</creator><creator>Vestergaard, E. M.</creator><general>John Wiley & Sons, Ltd</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope><scope>RC3</scope></search><sort><creationdate>201501</creationdate><title>Chromosomal microarray in fetuses with increased nuchal translucency</title><author>Lund, I. C. B. ; Christensen, R. ; Petersen, O. B. ; Vogel, I. ; Vestergaard, E. M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4216-c75a05020635a988e347daa59096989ec307651f1d8555865189549780a9c7ee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>array comparative genomic hybridization</topic><topic>chromosomal microarray</topic><topic>Chromosomes</topic><topic>Down syndrome</topic><topic>Down Syndrome - diagnosis</topic><topic>Down Syndrome - embryology</topic><topic>Down Syndrome - genetics</topic><topic>Female</topic><topic>Fetuses</topic><topic>genomic imbalance</topic><topic>Humans</topic><topic>nuchal translucency</topic><topic>Nuchal Translucency Measurement - methods</topic><topic>Polymerase Chain Reaction</topic><topic>Pregnancy</topic><topic>Pregnancy Trimester, First</topic><topic>Pregnancy, High-Risk</topic><topic>prenatal diagnosis</topic><topic>Prenatal Diagnosis - methods</topic><topic>Prospective Studies</topic><topic>Reproducibility of Results</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lund, I. C. B.</creatorcontrib><creatorcontrib>Christensen, R.</creatorcontrib><creatorcontrib>Petersen, O. B.</creatorcontrib><creatorcontrib>Vogel, I.</creatorcontrib><creatorcontrib>Vestergaard, E. M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Genetics Abstracts</collection><jtitle>Ultrasound in obstetrics & gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lund, I. C. B.</au><au>Christensen, R.</au><au>Petersen, O. B.</au><au>Vogel, I.</au><au>Vestergaard, E. M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chromosomal microarray in fetuses with increased nuchal translucency</atitle><jtitle>Ultrasound in obstetrics & gynecology</jtitle><addtitle>Ultrasound Obstet Gynecol</addtitle><date>2015-01</date><risdate>2015</risdate><volume>45</volume><issue>1</issue><spage>95</spage><epage>100</epage><pages>95-100</pages><issn>0960-7692</issn><eissn>1469-0705</eissn><coden>UOGYFJ</coden><abstract>ABSTRACT
Objective
To assess the clinical value of using high‐resolution chromosomal microarray (CMA) for the examination of genomic imbalances in prenatal uncultured chorionic villus samples from fetuses with increased nuchal translucency (NT) and a normal quantitative fluorescent polymerase chain reaction (QF‐PCR) result, in a clinical setting in which more than 95% of pregnant women receive first‐trimester combined screening.
Methods
From January 2013 to July 2014, we included 132 chorionic villus samples from consecutive ongoing pregnancies, with fetal NT ≥ 3.5 mm at 11–13 weeks' gestation, from obstetric units (publicly funded healthcare) in Central and North Denmark Regions. DNA was extracted directly from the samples and examined with QF‐PCR (n = 132) and 180 kb oligonucleotide array‐based comparative genomic hybridization (n = 94).
Results
In 38 cases, aneuploidies for chromosomes 18, 21 or X, or triploidy, were detected by QF‐PCR. Among the 94 cases with a normal QF‐PCR result, we detected pathogenic copy number variants (CNVs) by CMA in 12 fetuses (12.8% (95% CI, 7.5–21.0%)). In an additional three (3.2%) cases, CNVs with uncertain clinical significance were detected.
Conclusion
CMA is a valuable diagnostic technique in pregnancies with isolated fetal NT ≥ 3.5 mm. Copyright © 2014 ISUOG. Published by John Wiley & Sons Ltd.</abstract><cop>Chichester, UK</cop><pub>John Wiley & Sons, Ltd</pub><pmid>25393210</pmid><doi>10.1002/uog.14726</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0960-7692 |
ispartof | Ultrasound in obstetrics & gynecology, 2015-01, Vol.45 (1), p.95-100 |
issn | 0960-7692 1469-0705 |
language | eng |
recordid | cdi_proquest_miscellaneous_1647016180 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | array comparative genomic hybridization chromosomal microarray Chromosomes Down syndrome Down Syndrome - diagnosis Down Syndrome - embryology Down Syndrome - genetics Female Fetuses genomic imbalance Humans nuchal translucency Nuchal Translucency Measurement - methods Polymerase Chain Reaction Pregnancy Pregnancy Trimester, First Pregnancy, High-Risk prenatal diagnosis Prenatal Diagnosis - methods Prospective Studies Reproducibility of Results |
title | Chromosomal microarray in fetuses with increased nuchal translucency |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T04%3A55%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chromosomal%20microarray%20in%20fetuses%20with%20increased%20nuchal%20translucency&rft.jtitle=Ultrasound%20in%20obstetrics%20&%20gynecology&rft.au=Lund,%20I.%20C.%20B.&rft.date=2015-01&rft.volume=45&rft.issue=1&rft.spage=95&rft.epage=100&rft.pages=95-100&rft.issn=0960-7692&rft.eissn=1469-0705&rft.coden=UOGYFJ&rft_id=info:doi/10.1002/uog.14726&rft_dat=%3Cproquest_cross%3E1647016180%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4216-c75a05020635a988e347daa59096989ec307651f1d8555865189549780a9c7ee3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1641399002&rft_id=info:pmid/25393210&rfr_iscdi=true |